New discoveries in lung cancer biology: paving the road of personalized medicine
Computed tomography screening of smokers for lung cancer can reduce deaths
Trial finds endosonography more effective than mediastinoscopy for mediastinal nodal staging of lung cancer
Inhalable powder treatment for lung cancer shows promise
Should lung cancer in smokers and never smokers be studied separately?
Combining EGF receptor inhibitors with chemotherapy or chemoradiotherapy in patients with non-small-cell lung cancer
Afatinib (BIBW-2992): a novel dual EGFR/HER2neu inhibitor with promising activity in non-small-cell lung cancer
Neoadjuvant chemotherapy in lung cancer
Maintenance therapies in advanced non-small-cell lung cancer
Immunotherapy as a strategy for the treatment of non-small-cell lung cancer
EML4-ALK in non-small-cell lung cancer: the breathtaking progress from benchtop to Phase III clinical trial
US FDA approves denosumab for the prevention of cancer-related fractures
CYT107 (IL-7) in combination with raltegravir and maraviroc enters Phase II trial in HIV patients
US FDA approves testosterone topical solution CIII
New clinical trial results for severe malaria
Drug Approvals October to December 2010
Current perspective of stem cell therapies for cardiac regeneration
Risks and benefits of ileal pouch–anal anastomosis for ulcerative colitis
Acknowledgements